← Back to Search

Stent Graft

Valiant Evo Thoracic Stent Graft System for Thoracic Aortic Aneurysm (VEVO Trial)

N/A

Waitlist Available

Led By Ali Azizzadeh, MD

Research Sponsored by Medtronic Cardiovascular

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 month

Awards & highlights

VEVO Trial Summary

This trial is to test how safe and effective a new thoracic stent graft system is for people with a descending thoracic aortic aneurysm.

Eligible Conditions

Thoracic Aortic Aneurysm

VEVO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Composite Safety and Effectiveness Endpoint That is Based on the Percentage of Subjects Who Experienced (a) Access and/or Deployment Failures; and/or (b) Major Device Effect (MDE) Within 30 Days Post Index Procedure

Secondary outcome measures

Safety and Effectiveness Outcome

VEVO Trial Design

1Treatment groups

Experimental Treatment

Group I: Endovascular RepairExperimental Treatment1 Intervention

Valiant Evo Thoracic Stent Graft System

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Valiant Evo Thoracic Stent Graft System

2016

N/A

~200

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medtronic CardiovascularLead Sponsor

75 Previous Clinical Trials

36,232 Total Patients Enrolled

Ali Azizzadeh, MDPrincipal InvestigatorCedars-Sinai Heart Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what geographic areas is this clinical trial taking place?

"The clinical trial is presently taking place at Inova Fairfax Hospital in Falls Church, Virginia; Ohio State University in Minneapolis, Minnesota; and the University of Minnesota Medical Center in Houston, Texas. Additionally, it's being conducted across 22 other medical centres."

Answered by AI

Does this clinical trial have any vacancies for volunteers?

"This investigation, initially posted in April 2016 and recently modified on November 4th 2022, is no longer enrolling participants. Nevertheless, there are 152 other trials presently accepting patients."

Answered by AI

Recent research and studies

Journal of Vascular SurgeryJournal

Pivotal Results for the Valiant Navion Stent Graft System in the Valiant EVO Global Clinical Trial

Azizzadeh, Ali, Nimesh Desai, Frank R. Arko III, Jean M. Panneton, Fabien Thaveau, Paul Hayes, Francois Dagenais, Lanyu Lei, and Fabio Verzini. 2019. “Pivotal Results for the Valiant Navion Stent Graft System in the Valiant EVO Global Clinical Trial”. Journal of Vascular Surgery. Elsevier BV. doi:10.1016/j.jvs.2019.01.067.

Journal of Vascular SurgeryJournal

A Preliminary Analysis of Late Structural Failures of the Navion Stent Graft in the Treatment of Descending Thoracic Aortic Aneurysms

Verzini, Fabio, Enrico Cieri, Andrea Kahlberg, Yaron Sternbach, Robin Heijmen, Kenneth Ouriel, Sam Robaina, and Ali Azizzadeh. 2021. “A Preliminary Analysis of Late Structural Failures of the Navion Stent Graft in the Treatment of Descending Thoracic Aortic Aneurysms”. Journal of Vascular Surgery. Elsevier BV. doi:10.1016/j.jvs.2021.04.018.

clinicaltrials.govStudy

Valiant Evo US Clinical Trial

2016. "Valiant Evo US Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02652949.